Form 4 for IBOC INTERNATIONAL BANCSHARES CORP

Accepted 2025-09-09 00:00:00 ET · period of report 2025-09-05 · accession 0001415889-25-024008 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2025-09-09	2025-09-05	IBOC	WAWROSKI JUDITH I	Treas, PAO	D - Sale to Iss	$71.58	-600	11.2K	-5%	-$42.9K
D	2025-09-09	2025-09-05	IBOC	WAWROSKI JUDITH I	Treas, PAO	M - OptEx	$39.33	+600	11.8K	+5%	+$23.6K
D	2025-09-09	2025-09-05	IBOC	WAWROSKI JUDITH I	Treas, PAO	M - OptEx	$71.58	+600	3,400	+21%	+$42.9K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2025-09-05	D	D	600	$71.58	11,172	D	—	—	(F2) Represents the closing price of the Company's Common Stock on September 5, 2025, the date the SARs were exercised (the "Exercise Date").
2	Common	Common Stock	2025-09-05	M	A	600	$39.33	11,772	D	—	—
3	Derivative	STOCK APPRECIATION RIGHTS	2025-09-05	M	A	600	$71.58	3,400	D	$39.33 · 2025-07-14 to 2032-07-14	600 COMMON STOCK	(F3) These SARs represent the right to receive, upon exercise, a cash amount equal to the number of shares of the Company's Common Stock underlying the SARs being exercised multiplied by the excess of the fair market value of one share of Common Stock on (i) the Exercise Date, and (ii) July 14, 2022, the date the SARs were granted (the "Grant Date"). (F4) These SARs are subject to a seven-year vesting schedule and become exercisable in six percentage installments, vesting 5% on the second anniversary of the Grant Date, and 10%, 15%, 20%, 25%, and 25% on each respective anniversary of the Grant Date thereafter.